Tracleer recommended for earlier PAH use in EU
This article was originally published in Scrip
Executive Summary
Actelion's best-selling product Tracleer (bosentan) has been recommended by the EU's CHMP to treat earlier stage pulmonary arterial hypertension (PAH).